Delivery Order SPE2DB22D1103-SPE2DB25FTMF2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tafinlar 75 mg capsules (120 count) valued at $8,896.41, with an ultimate completion date of September 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $8,896.41 delivery order to AmerisourceBergen Drug Corp for Tafinlar 75 mg capsules (120 count) on July 17, 2025, with an ultimate completion date of August 7, 2025. This firm fixed price delivery order, issued without set-aside designation, was competitively awarded and performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single shipment of this oncology medication through AmerisourceBergen's established federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,896.41 to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120 count) on August 29, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract. The award, valued at $17,792.82, is set to be completed by September 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $8.9K delivery order to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract. The award, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 50 mg capsules (120 count) at a firm fixed price of $13,836.26. This is a non-set-aside contract with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) under a firm fixed-price contract valued at $27,672.52. This delivery order is expected to be completed by August 20, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's demonstrated...
- The Defense Logistics Agency awarded a $8,896.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Tafinlar 75 mg, a targeted cancer therapy medication. This contract, awarded on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a direct fulfillment order under the company's existing indefinite delivery contract with DLA Troop Support Medical. The award carries no set-aside designation and was competitively awarded through open...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,810 units of the pharmaceutical product Tafinlar 75 mg capsules. The order has an ultimate completion date of October 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a range...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) with a ceiling value of $13,836.26. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded, non-set-aside contract with no small business preferences applied. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTMF2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,896.41 to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120-count units), with an ultimate completion date of May 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, was selected through open competition to fulfill this pharmaceutical supply requirement. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The parent IDC enables the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's proven capability to meet federal procurement requirements across multiple therapeutic domains through competitive awards positions it as a key provider within DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 5/8/25 |